Respiratory Syncytial Virus Vaccine

FDA Drug Profile — Abrysvo, mRESVIA

Respiratory Syncytial Virus Vaccine is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand names including Abrysvo, mRESVIA. Available dosage forms: suspension, injection, powder, lyophilized, for solution.

Drug details

Generic Name
Respiratory Syncytial Virus Vaccine
Brand Names
Abrysvo, mRESVIA
Application Number
BLA125769
Sponsor
ROVI Pharma Industrial Services S.A.
NDC Codes
7
Dosage Forms
SUSPENSION, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAMUSCULAR
Active Ingredients
RNA-100-AR02, RECOMBINANT STABILIZED RSV A PREFUSION F ANTIGEN, RECOMBINANT STABILIZED RSV B PREFUSION F ANTIGEN

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.